Skip to main content

Class of 1955’s timely investment: supporting student health

Members of the Class of 1955 recently celebrated their 65th Reunion. These octogenarians have also been steadfast supporters of Cornell Health.


You Can Make it Happen: Fall 2020

You Can Make it Happen: makers in information science, music on the Arts Quad, conservation of an important work of art, and digitization of campus activism collection.


Journaling project, now global, welcomes COVID-19 stories

As the coronavirus pandemic unfolded, students in Janis Whitlock’s graduate seminar on translational research found themselves in a unique position – being able to participate in a widespread journaling project to record their hopes, fears and routines, chronicling COVID-19’s effects on their daily lives and relationships.


Project to optimize food plant worker safety, product supply

A Cornell-led project will use computer modeling and outreach to find optimal strategies to minimize COVID-19 cases and transmission among workers in food processing facilities, while maintaining the best possible production.

Winter Sessions courses, all online, open for registration

Due to the pandemic, Cornell’s Winter Session, scheduled for Jan. 4-23, 2021, will be held entirely online for the first time. Registration is now open.


Panel offers look at open access in the COVID-19 era

When COVID-19 struck, arXiv's mission, to make scientific research free and openly accessible, became even more urgent.

Silver linings: Innovation, kits, tech animate a hybrid semester

This semester, virtual, in-person and hybrid classes across disciplines are employing innovative ways to leave students with safe but lasting educational experiences.

Music faculty’s pandemic response hitting the right notes

Instrumental music professors have gotten creative during the pandemic, using various approaches to teaching this semester in an effort to give their students the best experience possible.

Efficacy, politics influence public trust in COVID-19 vaccine

In surveys of nearly 2,000 American adults, barely half said they would be willing to take a hypothetical vaccine with an efficacy, or effectiveness, of 50% – the U.S. Food and Drug Administration’s minimum threshold for a COVID-19 vaccine.